Patented Ultra-Fine Needle Technology And Surgical Process Revolution

1. Process Backward Pain Points of Traditional OPU Surgery

Traditional OPU egg retrieval surgical processes have long been restricted by backward equipment technology, forming cumbersome, high-risk and high-cost industry pain points. Limited by thick-gauge traditional needle trauma, conventional egg retrieval surgery must be matched with general anesthesia preoperative preparation and postoperative in-hospital observation, resulting in lengthy surgical procedures, high time cost and high medical risk. Anesthesia intervention not only increases patients' economic burden, but also brings potential safety hazards such as anesthesia intolerance and postoperative complications. Traditional thick needles have low single aspiration efficiency, often requiring repeated follicle flushing and secondary puncture, which prolongs surgical time and increases tissue trauma. In addition, traditional equipment cannot adapt to complex surgical scenarios such as hydrosalpinx and ovarian cysts, requiring multi-equipment combined operation, further complicating the surgical process. The solidified backward process mode restricts the improvement of clinical treatment efficiency and patient experience, and hinders the iterative upgrading of the assisted reproductive industry.

2. Patented Technology-Driven Process Optimization Principle

The self-developed national patented ultra-fine OPU needle technology realizes a revolutionary optimization of the traditional surgical process through minimally invasive technological breakthroughs. The core optimization principle is to reduce surgical trauma to the minimum through ultra-fine cross-section design and upgraded triple-cut blade, thereby eliminating redundant and high-risk auxiliary procedures from the source. The patented needle's cross-sectional area is only one quarter of traditional needles, with ultra-low intraoperative bleeding and pain, completely getting rid of the dependence on general anesthesia. The high-precision polished lumen realizes one-time efficient oocyte aspiration without repeated flushing, simplifying intraoperative operation steps. The exclusive 23G ultra-fine specification has the precision of blood collection needles, which can complete complex operations such as cyst cleaning and hydrosalpinx extraction independently, realizing multi-scenario one-piece operation. The minimal trauma after operation eliminates the need for in-hospital observation, realizing the revolutionary simplification of the whole surgical process from "anesthesia-operation-observation" to "direct operation and immediate discharge".

3. Classification of Traditional and Patented Innovative Surgical Equipment

According to technical attributes and process adaptation, OPU surgical equipment is divided into traditional backward equipment and patented innovative upgraded equipment. Traditional ordinary needles (16G-19G conventional thick gauge): no independent patent technology, large surgical trauma, low operation efficiency, requiring anesthesia assistance and hospitalization observation, single functional scenario, cumbersome supporting processes, belonging to backward equipment restricting surgical process upgrading. Patented innovative ultra-fine needles (23G exclusive specification): national authorized invention patent, ultra-fine minimally invasive structure, multi-functional integrated performance, realizing anesthesia-free, non-flushing and non-hospitalization simplified surgery, covering conventional egg retrieval and complex cyst/hydrosalpinx treatment scenarios. This exclusive patented equipment is not available in other manufacturers and medical institutions, forming an irreplaceable technical and process advantage in the industry.

4. Simplified Innovative Surgical Operation Guidelines

Formulate standardized simplified surgical processes based on patented ultra-fine needle technology to replace traditional backward procedures. Preoperative procedure optimization: cancel routine general anesthesia preparation, only complete conventional vaginal disinfection and ultrasound positioning, greatly shortening preoperative waiting and preparation time. Intraoperative simplified operation: adopt 23G patented ultra-fine needle for one-time precise puncture and efficient aspiration, no repeated flushing and secondary adjustment needed; complete conventional egg retrieval and complex lesion cleaning in one operation, realizing multi-scenario integrated treatment. Postoperative procedure cancellation: eliminate mandatory hospitalization observation links, complete local disinfection after needle withdrawal, and patients can recover and leave the hospital immediately after resting for a short time. The whole process simplifies more than 60% of redundant procedures of traditional surgery, realizing lightweight and efficient outpatient minimally invasive treatment.

5. Practical Experience of Surgical Process Revolution

Clinical practical data fully prove the revolutionary value of patented ultra-fine needle technology in surgical process optimization. Compared with traditional surgical modes, the innovative simplified process reduces single surgical time by more than 50%, and the daily treatment capacity of reproductive centers is increased by 40%. The complete elimination of general anesthesia avoids all anesthesia-related risks and reduces patients' treatment costs by more than 35%. The cancellation of hospitalization observation greatly improves medical bed turnover efficiency and reduces hospital operating pressure. In complex surgical scenarios that originally required multi-equipment combined operation, the exclusive patented 23G needle can complete independent treatment, simplifying the surgical process and improving operation precision. Long-term clinical follow-up shows that the simplified innovative process has zero increased complication rate, higher surgical safety and stability than traditional processes, and greatly improved patient satisfaction and medical efficiency.

6. Process Revolution Summary and Sublimation

The patented ultra-fine OPU needle technology drives a comprehensive revolution in the surgical process of assisted reproductive egg retrieval, completely breaking the long-term solidified backward mode of traditional surgery relying on anesthesia and hospitalization. Equipment technological innovation is the core driving force of surgical process upgrading, realizing the simplification, lightweight and high-efficiency transformation of clinical procedures from the source. The elimination of redundant high-risk procedures not only improves surgical safety and medical efficiency, but also reduces patients' economic and time costs, realizing the dual improvement of clinical value and social value. This technological and process dual innovation leads the industry to get rid of backward development modes and move towards high-quality, efficient and humanized refined medical treatment.

7. Process Upgrading Prospects and Industry Suggestions

In the future, anesthesia-free and non-hospitalization simplified minimally invasive surgery will become the universal standard of the OPU industry, and traditional cumbersome surgical processes will be completely eliminated. It is suggested that medical institutions accelerate the replacement of traditional backward equipment, fully popularize patented ultra-fine needle simplified surgical processes, and establish new outpatient rapid egg retrieval service systems. Equipment enterprises continue to optimize patented ultra-fine needle structural performance, enrich multi-scenario adaptive functions, and further improve the simplicity and efficiency of surgical processes. Industry associations formulate unified innovative simplified surgical specifications, promote the comprehensive popularization of new technologies and new processes, and lead the overall upgrading of the assisted reproductive surgery industry.